Suven Pharmaceuticals Limited

Suven Pharmaceuticals Limited: Carbon Emissions and Climate Commitments

Suven Pharmaceuticals Limited, headquartered in India and operating in the Pharmaceutical Preparation Manufacturing industry, has established significant climate commitments.

Emissions Data:

For the fiscal year 2024, Suven Pharmaceuticals reported Scope 1 emissions of approximately 41,183,000 kg CO2e and Scope 2 emissions of approximately 22,941,000 kg CO2e. This equates to a total of approximately 64,124,000 kg CO2e for Scopes 1 and 2.

In the preceding year, fiscal year 2023, the company recorded Scope 1 emissions of approximately 48,594,000 kg CO2e and Scope 2 emissions of approximately 33,723,000 kg CO2e, totalling approximately 82,317,000 kg CO2e for Scopes 1 and 2.

Scope 3 emissions data is not currently available.

Climate Commitments and Reduction Targets:

Suven Pharmaceuticals Limited has set ambitious targets aligned with the Science Based Targets initiative (SBTi) to combat climate change. The company has committed to:

• Near-Term Targets (by FY2033, from a FY2023 base year):
  • A 54.6% reduction in absolute Scope 1 greenhouse gas (GHG) emissions.
  • A 54.6% reduction in absolute Scope 2 GHG emissions.
  • A 54.6% reduction in absolute Scope 3 GHG emissions.
• Long-Term Targets:
  • Achieve net-zero greenhouse gas emissions across the value chain by FY2050.
  • A 90% reduction in absolute Scope 1 GHG emissions by FY2050 (from a FY2023 base year).
  • A 90% reduction in absolute Scope 2 GHG emissions by FY2050 (from a FY2023 base year).
  • A 90% reduction in absolute Scope 3 GHG emissions by FY2050.

These targets are consistent with limiting global warming to 1.5°C. The company also has a general commitment to a 15% reduction in CO2 emissions per metric ton (MT) produced, with a target for completion between 2023 and 2025.